SP70 is a novel biomarker of hepatocellular carcinoma.

Lin Wang,Hui Shi, Jia Wei,Wen-Xiu Chen,Yue-Xinzi Jin,Chun-Rong Gu,Yuan Mu,Jian Xu,Shi-Yang Pan

Frontiers in oncology（2023）

引用 0|浏览14

暂无评分

摘要

SP70 is a promising biomarker in diagnosing HCC. High preoperative serum SP70 level is associated with an increased risk of early relapse and could be used as a valuable marker to predict early recurrence of HCC after resection.

查看译文

关键词

SP70,diagnostic performance,early recurrence,hepatocellular carcinoma,recurrence-free survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要